Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Chlorhexidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomatitis 2 Mouth Neoplasms 2 Head and Neck Neoplasms 2 Wound Infection 1 Squamous Cell Carcinoma of Head and Neck 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Bacterial Infections 1

Interventions

Carboplatin 648 Pemetrexed 507 Cisplatin 461 Paclitaxel 398 pembrolizumab 383 Docetaxel 372 Gemcitabine 274 Erlotinib Hydrochloride 264 Radiotherapy 218 Bevacizumab 196 Nivolumab 195 osimertinib 144 Drug Therapy 130 durvalumab 129 Gefitinib 114 atezolizumab 109 Radiosurgery 108 Vinorelbine 95 Cetuximab 82 130-nm albumin-bound paclitaxel 79 Magnetic Resonance Spectroscopy 77 Surgical Procedures, Operative 65 Ipilimumab 65 Taxes 62 Albumin-Bound Paclitaxel 56 Specimen Handling 53 Cyclophosphamide 53 tislelizumab 52 Afatinib 52 Etoposide 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06120140 2026-03-13

COCOON

Janssen Research & Development, LLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡